VCA Inc (NASDAQ:WOOF) was upgraded by Zacks Investment Research from a “sell” rating to a “hold” rating in a research note issued to investors on Saturday.
According to Zacks, “VCA Inc. is a national animal healthcare company operating primarily in the United States and Canada. It owns, operates and manages veterinary hospitals and veterinary-exclusive clinical laboratories in the country, supplies diagnostic imaging equipment and other medical technology products and related services to the veterinary industry, and provides various communication, professional education and marketing solutions to the veterinary community. VCA Inc., formerly known as VCA Antech, Inc., is headquartered in Los Angeles, California. “
Other equities research analysts have also recently issued research reports about the stock. Jefferies Group LLC restated a “hold” rating and set a $93.00 target price on shares of VCA in a research note on Friday, March 17th. Benchmark Co. cut shares of VCA from a “buy” rating to a “hold” rating in a research note on Thursday, February 16th. Raymond James Financial, Inc. cut shares of VCA from a “strong-buy” rating to a “market perform” rating in a research note on Tuesday, January 10th. William Blair cut shares of VCA from an “outperform” rating to a “market perform” rating in a research note on Monday, January 9th. Finally, CL King cut shares of VCA from a “buy” rating to a “neutral” rating in a research note on Thursday, January 26th. Seven equities research analysts have rated the stock with a hold rating and two have given a buy rating to the company’s stock. The company has a consensus rating of “Hold” and an average price target of $84.67.
Shares of VCA (NASDAQ:WOOF) traded up 0.14% during trading on Friday, reaching $91.63. 634,311 shares of the company were exchanged. VCA has a 52-week low of $59.51 and a 52-week high of $91.96. The stock’s 50-day moving average is $91.43 and its 200-day moving average is $78.74. The firm has a market cap of $7.44 billion, a price-to-earnings ratio of 35.79 and a beta of 1.03.
VCA (NASDAQ:WOOF) last released its earnings results on Thursday, February 9th. The company reported $0.58 EPS for the quarter, missing analysts’ consensus estimates of $0.60 by $0.02. VCA had a return on equity of 16.03% and a net margin of 8.31%. The firm had revenue of $643.10 million for the quarter, compared to the consensus estimate of $642.28 million. During the same quarter in the previous year, the business posted $0.50 EPS. VCA’s revenue was up 20.5% on a year-over-year basis. Equities research analysts predict that VCA will post $3.27 earnings per share for the current fiscal year.
Several large investors have recently added to or reduced their stakes in WOOF. BNP Paribas Arbitrage SA boosted its stake in VCA by 1.1% in the third quarter. BNP Paribas Arbitrage SA now owns 64,597 shares of the company’s stock valued at $4,520,000 after buying an additional 677 shares during the last quarter. Oregon Public Employees Retirement Fund boosted its stake in VCA by 2.0% in the third quarter. Oregon Public Employees Retirement Fund now owns 27,939 shares of the company’s stock valued at $1,955,000 after buying an additional 557 shares during the last quarter. Fisher Asset Management LLC bought a new stake in VCA during the third quarter valued at about $204,000. Creative Planning boosted its stake in VCA by 36.3% in the third quarter. Creative Planning now owns 3,480 shares of the company’s stock valued at $244,000 after buying an additional 926 shares during the last quarter. Finally, Atria Investments LLC bought a new stake in VCA during the third quarter valued at about $273,000. Hedge funds and other institutional investors own 86.95% of the company’s stock.
VCA Inc is an animal healthcare company operating in the United States and Canada. The Company operates through five segments: animal hospitals (Animal Hospital), veterinary diagnostic laboratories (Laboratory), veterinary medical technology (Medical Technology), Vetstreet and Camp Bow Wow Franchising, Inc (Camp Bow Wow).
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Receive News & Ratings for VCA Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for VCA Inc and related companies with our FREE daily email newsletter.